Mobia Medical names Reza Zadno to board as independent director
MOBI•Board appointment
Mobia Medical named Reza Zadno to its board as an independent director, effective July 14, 2026.
- Zadno will join the compensation committee.
- He previously served as CEO of PROCEPT BioRobotics from February 2020 to September 2025, leading its 2021 IPO.
- He also led Avedro as CEO, a public ophthalmology company later acquired by Glaukos.
- Zadno is an operating partner at Jolt Capital.
